Skip to main content
Top
Published in: Cancer Cell International 1/2009

Open Access 01-12-2009 | Primary research

Establishment and characterization of three new human breast cancer cell lines derived from Chinese breast cancer tissues

Authors: Chao Shen, Meijia Gu, Dan Liang, Lixia Miao, Liu Hu, Congyi Zheng, Jiakuan Chen

Published in: Cancer Cell International | Issue 1/2009

Login to get access

Abstract

Background

Breast cancer is a major malignancy affecting females worldwide. It is the most common cause of death from cancer in women. Cell lines are widely used in laboratory research and particularly as in vitro models in cancer research. But we found that the routinely used breast cancer cell lines were mostly derived from Caucasians or African-Americans. There were few standard models to study the pathogenic mechanism at molecular level and cell signaling pathway of breast cancer for Asian patients. It is quite necessary to establish new breast cancer cell lines from xanthoderm to study the pathogenic mechanism and therapeutic methods.

Results

Three new breast cancer cell lines, designated BC-019, BC-020 and BC-021, were successfully established and characterized from breast invasive ductal carcinoma tissues of three Chinese female patients. These new cell lines growing as adherent monolayer with characteristic epithelial morphology could be maintained continuously in vitro, and they were ER-, PR- and C-erbB-2-positive. Their chromosomes showed high hyperdiploidy and complex rearrangements, and they displayed aggressive tumorigencity in tumorigenesis test.

Conclusion

The three newly established breast cancer cell lines from Chinese patients were tested for a number of, and the results indicate that the cell lines were in good quality and could be served as new cell models in breast cancer study.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bertero C, Chamberlain Wilmoth M: Breast cancer diagnosis and its treatment affecting the self: a meta-synthesis. Cancer Nurs. 2007, 30 (3): 194-202. 10.1097/01.NCC.0000270707.80037.4c. quiz 203–194CrossRefPubMed Bertero C, Chamberlain Wilmoth M: Breast cancer diagnosis and its treatment affecting the self: a meta-synthesis. Cancer Nurs. 2007, 30 (3): 194-202. 10.1097/01.NCC.0000270707.80037.4c. quiz 203–194CrossRefPubMed
2.
go back to reference Wiseman MJ: The World Cancer Research Fund Expert Report: the next steps. IARC Sci Publ. 2002, 156: 523-524.PubMed Wiseman MJ: The World Cancer Research Fund Expert Report: the next steps. IARC Sci Publ. 2002, 156: 523-524.PubMed
3.
go back to reference Stewart BW, Kleihues P: World Cancer Report. 2003, Lyon: International Agency for Research on Cancer Stewart BW, Kleihues P: World Cancer Report. 2003, Lyon: International Agency for Research on Cancer
4.
go back to reference Soule HD, Vazguez J, Long A, Albert S, Brennan M: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst. 1973, 51 (5): 1409-1416.PubMed Soule HD, Vazguez J, Long A, Albert S, Brennan M: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst. 1973, 51 (5): 1409-1416.PubMed
6.
go back to reference Engel LW, Young NA: Human breast carcinoma cells in continuous culture: a review. Cancer Res. 1978, 38 (11 Pt 2): 4327-4339.PubMed Engel LW, Young NA: Human breast carcinoma cells in continuous culture: a review. Cancer Res. 1978, 38 (11 Pt 2): 4327-4339.PubMed
7.
go back to reference Keydar I, Chen L, Karby S, Weiss FR, Delarea J, Radu M, Chaitcik S, Brenner HJ: Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer. 1979, 15 (5): 659-670.CrossRefPubMed Keydar I, Chen L, Karby S, Weiss FR, Delarea J, Radu M, Chaitcik S, Brenner HJ: Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer. 1979, 15 (5): 659-670.CrossRefPubMed
8.
go back to reference Xu X, Wang B, Ye C, Yao C, Lin Y, Huang X, Zhang Y, Wang S: Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer. Cancer Lett. 2008, 261 (2): 147-157. 10.1016/j.canlet.2007.11.028.CrossRefPubMed Xu X, Wang B, Ye C, Yao C, Lin Y, Huang X, Zhang Y, Wang S: Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer. Cancer Lett. 2008, 261 (2): 147-157. 10.1016/j.canlet.2007.11.028.CrossRefPubMed
9.
go back to reference Lixia M, Zhijian C, Chao S, Chaojiang G, Congyi Z: Alternative splicing of breast cancer associated gene BRCA1 from breast cancer cell line. J Biochem Mol Biol. 2007, 40 (1): 15-21.CrossRefPubMed Lixia M, Zhijian C, Chao S, Chaojiang G, Congyi Z: Alternative splicing of breast cancer associated gene BRCA1 from breast cancer cell line. J Biochem Mol Biol. 2007, 40 (1): 15-21.CrossRefPubMed
10.
go back to reference Yang L, Parkin DM, Li L, Chen Y: Time trends in cancer mortality in China: 1987–1999. Int J Cancer. 2003, 106 (5): 771-783. 10.1002/ijc.11300.CrossRefPubMed Yang L, Parkin DM, Li L, Chen Y: Time trends in cancer mortality in China: 1987–1999. Int J Cancer. 2003, 106 (5): 771-783. 10.1002/ijc.11300.CrossRefPubMed
11.
go back to reference Ma H, Hu Z, Zhai X, Wang S, Wang X, Qin J, Jin G, Liu J, Wang X, Wei Q: Polymorphisms in the MDM2 promoter and risk of breast cancer: a case-control analysis in a Chinese population. Cancer Lett. 2006, 240 (2): 261-267. 10.1016/j.canlet.2005.09.019.CrossRefPubMed Ma H, Hu Z, Zhai X, Wang S, Wang X, Qin J, Jin G, Liu J, Wang X, Wei Q: Polymorphisms in the MDM2 promoter and risk of breast cancer: a case-control analysis in a Chinese population. Cancer Lett. 2006, 240 (2): 261-267. 10.1016/j.canlet.2005.09.019.CrossRefPubMed
12.
go back to reference Hu Y, Lam KY, Wan TS, Fang W, Ma ES, Chan LC, Srivastava G: Establishment and characterization of HKESC-1, a new cancer cell line from human esophageal squamous cell carcinoma. Cancer Genet Cytogenet. 2000, 118 (2): 112-120. 10.1016/S0165-4608(99)00193-4.CrossRefPubMed Hu Y, Lam KY, Wan TS, Fang W, Ma ES, Chan LC, Srivastava G: Establishment and characterization of HKESC-1, a new cancer cell line from human esophageal squamous cell carcinoma. Cancer Genet Cytogenet. 2000, 118 (2): 112-120. 10.1016/S0165-4608(99)00193-4.CrossRefPubMed
13.
go back to reference Denizot F, Lang R: Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods. 1986, 89 (2): 271-277. 10.1016/0022-1759(86)90368-6.CrossRefPubMed Denizot F, Lang R: Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods. 1986, 89 (2): 271-277. 10.1016/0022-1759(86)90368-6.CrossRefPubMed
14.
go back to reference Garcia CC, Candurra NA, Damonte EB: Mode of inactivation of arenaviruses by disulfide-based compounds. Antiviral Res. 2002, 55 (3): 437-446. 10.1016/S0166-3542(02)00076-1.CrossRefPubMed Garcia CC, Candurra NA, Damonte EB: Mode of inactivation of arenaviruses by disulfide-based compounds. Antiviral Res. 2002, 55 (3): 437-446. 10.1016/S0166-3542(02)00076-1.CrossRefPubMed
15.
go back to reference Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983, 65 (1–2): 55-63. 10.1016/0022-1759(83)90303-4.CrossRefPubMed Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983, 65 (1–2): 55-63. 10.1016/0022-1759(83)90303-4.CrossRefPubMed
16.
go back to reference Bernhard D, Schwaiger W, Crazzolara R, Tinhofer I, Kofler R, Csordas A: Enhanced MTT-reducing activity under growth inhibition by resveratrol in CEM-C7H2 lymphocytic leukemia cells. Cancer Lett. 2003, 195 (2): 193-199.CrossRefPubMed Bernhard D, Schwaiger W, Crazzolara R, Tinhofer I, Kofler R, Csordas A: Enhanced MTT-reducing activity under growth inhibition by resveratrol in CEM-C7H2 lymphocytic leukemia cells. Cancer Lett. 2003, 195 (2): 193-199.CrossRefPubMed
17.
go back to reference Hay RJ, Caputo J, Macy ML: ATCC quality control methods for cell lines. 1992, Rockville: American Type Culture Collection, Second Hay RJ, Caputo J, Macy ML: ATCC quality control methods for cell lines. 1992, Rockville: American Type Culture Collection, Second
18.
go back to reference Mavi A, Cermik TF, Urhan M, Puskulcu H, Basu S, Yu JQ, Zhuang H, Czerniecki B, Alavi A: The effects of estrogen, progesterone, and C-erbB-2 receptor states on 18F-FDG uptake of primary breast cancer lesions. J Nucl Med. 2007, 48 (8): 1266-1272. 10.2967/jnumed.106.037440.CrossRefPubMed Mavi A, Cermik TF, Urhan M, Puskulcu H, Basu S, Yu JQ, Zhuang H, Czerniecki B, Alavi A: The effects of estrogen, progesterone, and C-erbB-2 receptor states on 18F-FDG uptake of primary breast cancer lesions. J Nucl Med. 2007, 48 (8): 1266-1272. 10.2967/jnumed.106.037440.CrossRefPubMed
19.
go back to reference Gago FE, Fanelli MA, Ciocca DR: Co-expression of steroid hormone receptors (estrogen receptor alpha and/or progesterone receptors) and Her2/neu (c-erbB-2) in breast cancer: clinical outcome following tamoxifen-based adjuvant therapy. J Steroid Biochem Mol Biol. 2006, 98 (1): 36-40. 10.1016/j.jsbmb.2005.07.002.CrossRefPubMed Gago FE, Fanelli MA, Ciocca DR: Co-expression of steroid hormone receptors (estrogen receptor alpha and/or progesterone receptors) and Her2/neu (c-erbB-2) in breast cancer: clinical outcome following tamoxifen-based adjuvant therapy. J Steroid Biochem Mol Biol. 2006, 98 (1): 36-40. 10.1016/j.jsbmb.2005.07.002.CrossRefPubMed
20.
go back to reference Luna-More S, de los Santos F, Breton JJ, Canadas MA: Estrogen and progesterone receptors, c-erbB-2, p53, and Bcl-2 in thirty-three invasive micropapillary breast carcinomas. Pathol Res Pract. 1996, 192 (1): 27-32.CrossRefPubMed Luna-More S, de los Santos F, Breton JJ, Canadas MA: Estrogen and progesterone receptors, c-erbB-2, p53, and Bcl-2 in thirty-three invasive micropapillary breast carcinomas. Pathol Res Pract. 1996, 192 (1): 27-32.CrossRefPubMed
21.
go back to reference Zhang S, Yuan Y, Wang X: Prognosis prediction of S-phase fraction and p53, c-erbB-2, estrogen receptor, progesterone receptor in axillary node-negative breast cancer. Zhonghua Wai Ke Za Zhi. 1997, 35 (8): 475-477.PubMed Zhang S, Yuan Y, Wang X: Prognosis prediction of S-phase fraction and p53, c-erbB-2, estrogen receptor, progesterone receptor in axillary node-negative breast cancer. Zhonghua Wai Ke Za Zhi. 1997, 35 (8): 475-477.PubMed
22.
go back to reference Hamada K, Shirakawa T, Gotoh A, Roth JA, Follen M: Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer. Gynecol Oncol. 2006, 103 (3): 820-830. 10.1016/j.ygyno.2006.06.035.CrossRefPubMed Hamada K, Shirakawa T, Gotoh A, Roth JA, Follen M: Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer. Gynecol Oncol. 2006, 103 (3): 820-830. 10.1016/j.ygyno.2006.06.035.CrossRefPubMed
23.
go back to reference Katagiri Y, Hozumi Y, Kondo S: Knockdown of Skp2 by siRNA inhibits melanoma cell growth in vitro and in vivo. J Dermatol Sci. 2006, 42 (3): 215-224. 10.1016/j.jdermsci.2005.12.016.CrossRefPubMed Katagiri Y, Hozumi Y, Kondo S: Knockdown of Skp2 by siRNA inhibits melanoma cell growth in vitro and in vivo. J Dermatol Sci. 2006, 42 (3): 215-224. 10.1016/j.jdermsci.2005.12.016.CrossRefPubMed
24.
go back to reference Ryoo ZY, Jung BK, Lee SR, Kim MO, Kim SH, Kim HJ, Ahn JY, Lee TH, Cho YH, Park JH: Neoplastic transformation and tumorigenesis associated with overexpression of IMUP-1 and IMUP-2 genes in cultured NIH/3T3 mouse fibroblasts. Biochem Biophys Res Commun. 2006, 349 (3): 995-1002. 10.1016/j.bbrc.2006.08.137.CrossRefPubMed Ryoo ZY, Jung BK, Lee SR, Kim MO, Kim SH, Kim HJ, Ahn JY, Lee TH, Cho YH, Park JH: Neoplastic transformation and tumorigenesis associated with overexpression of IMUP-1 and IMUP-2 genes in cultured NIH/3T3 mouse fibroblasts. Biochem Biophys Res Commun. 2006, 349 (3): 995-1002. 10.1016/j.bbrc.2006.08.137.CrossRefPubMed
25.
go back to reference Kok SH, Hong CY, Lin SK, Lee JJ, Chiang CP, Kuo MY: Establishment and characterization of a tumorigenic cell line from areca quid and tobacco smoke-associated buccal carcinoma. Oral Oncol. 2007, 43 (7): 639-647. 10.1016/j.oraloncology.2006.07.007.CrossRefPubMed Kok SH, Hong CY, Lin SK, Lee JJ, Chiang CP, Kuo MY: Establishment and characterization of a tumorigenic cell line from areca quid and tobacco smoke-associated buccal carcinoma. Oral Oncol. 2007, 43 (7): 639-647. 10.1016/j.oraloncology.2006.07.007.CrossRefPubMed
26.
go back to reference Nishio J, Iwasaki H, Ishiguro M, Ohjimi Y, Yo S, Isayama T, Naito M, Kikuchi M: Supernumerary ring chromosome in a Bednar tumor (pigmented dermatofibrosarcoma protuberans) is composed of interspersed sequences from chromosomes 17 and 22: a fluorescence in situ hybridization and comparative genomic hybridization analysis. Genes Chromosomes Cancer. 2001, 30 (3): 305-309. 10.1002/1098-2264(2000)9999:9999<::AID-GCC1091>3.0.CO;2-R.CrossRefPubMed Nishio J, Iwasaki H, Ishiguro M, Ohjimi Y, Yo S, Isayama T, Naito M, Kikuchi M: Supernumerary ring chromosome in a Bednar tumor (pigmented dermatofibrosarcoma protuberans) is composed of interspersed sequences from chromosomes 17 and 22: a fluorescence in situ hybridization and comparative genomic hybridization analysis. Genes Chromosomes Cancer. 2001, 30 (3): 305-309. 10.1002/1098-2264(2000)9999:9999<::AID-GCC1091>3.0.CO;2-R.CrossRefPubMed
27.
go back to reference Nishio J, Iwasaki H, Ishiguro M, Ohjimi Y, Nishimura N, Koga T, Kawarabayashi T, Kaneko Y, Kikuchi M: Establishment of a new human malignant fibrous histiocytoma cell line, FU-MFH-1: cytogenetic characterization by comparative genomic hybridization and fluorescence in situ hybridization. Cancer Genet Cytogenet. 2003, 144 (1): 44-51. 10.1016/S0165-4608(02)00925-1.CrossRefPubMed Nishio J, Iwasaki H, Ishiguro M, Ohjimi Y, Nishimura N, Koga T, Kawarabayashi T, Kaneko Y, Kikuchi M: Establishment of a new human malignant fibrous histiocytoma cell line, FU-MFH-1: cytogenetic characterization by comparative genomic hybridization and fluorescence in situ hybridization. Cancer Genet Cytogenet. 2003, 144 (1): 44-51. 10.1016/S0165-4608(02)00925-1.CrossRefPubMed
28.
go back to reference Isaka K, Nishi H, Sagawa Y, Nakada T, Osakabe Y, Serizawa H, Ebihara Y, Takayama M: Establishment of a new human cell line (EN) with TP53 mutation derived from endometrial carcinoma. Cancer Genet Cytogenet. 2003, 141 (1): 20-25. 10.1016/S0165-4608(02)00673-8.CrossRefPubMed Isaka K, Nishi H, Sagawa Y, Nakada T, Osakabe Y, Serizawa H, Ebihara Y, Takayama M: Establishment of a new human cell line (EN) with TP53 mutation derived from endometrial carcinoma. Cancer Genet Cytogenet. 2003, 141 (1): 20-25. 10.1016/S0165-4608(02)00673-8.CrossRefPubMed
29.
go back to reference Cailleau R, Olive M, Cruciger QV: Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro. 1978, 14 (11): 911-915. 10.1007/BF02616120.CrossRefPubMed Cailleau R, Olive M, Cruciger QV: Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro. 1978, 14 (11): 911-915. 10.1007/BF02616120.CrossRefPubMed
30.
go back to reference Price JE, Polyzos A, Zhang RD, Daniels LM: Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res. 1990, 50 (3): 717-721.PubMed Price JE, Polyzos A, Zhang RD, Daniels LM: Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res. 1990, 50 (3): 717-721.PubMed
31.
go back to reference Gudjonsson T, Villadsen R, Ronnov-Jessen L, Petersen OW: Immortalization protocols used in cell culture models of human breast morphogenesis. Cell Mol Life Sci. 2004, 61 (19–20): 2523-2534. 10.1007/s00018-004-4167-z.CrossRefPubMed Gudjonsson T, Villadsen R, Ronnov-Jessen L, Petersen OW: Immortalization protocols used in cell culture models of human breast morphogenesis. Cell Mol Life Sci. 2004, 61 (19–20): 2523-2534. 10.1007/s00018-004-4167-z.CrossRefPubMed
32.
go back to reference Rubner Fridriksdottir AJ, Gudjonsson T, Halldorsson T, Bjornsson J, Steinarsdottir M, Johannsson OT, Ogmundsdottir HM: Establishment of three human breast epithelial cell lines derived from carriers of the 999del5 BRCA2 Icelandic founder mutation. In Vitro Cell Dev Biol Anim. 2005, 41 (10): 337-342. 10.1290/0505033.1.CrossRefPubMed Rubner Fridriksdottir AJ, Gudjonsson T, Halldorsson T, Bjornsson J, Steinarsdottir M, Johannsson OT, Ogmundsdottir HM: Establishment of three human breast epithelial cell lines derived from carriers of the 999del5 BRCA2 Icelandic founder mutation. In Vitro Cell Dev Biol Anim. 2005, 41 (10): 337-342. 10.1290/0505033.1.CrossRefPubMed
Metadata
Title
Establishment and characterization of three new human breast cancer cell lines derived from Chinese breast cancer tissues
Authors
Chao Shen
Meijia Gu
Dan Liang
Lixia Miao
Liu Hu
Congyi Zheng
Jiakuan Chen
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2009
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/1475-2867-9-2

Other articles of this Issue 1/2009

Cancer Cell International 1/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine